Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27

Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies

(2015) Shanliang Zhong et al.   BREAST CANCER RESEARCH AND TREATMENT

Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis

(2015) Xuan-zhang Huang et al.   CANCER CAUSES & CONTROL

Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice

(2014) Tsz Yan Wong et al.   BMC CANCER

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study

(2014) D M Fraser et al.   BRITISH JOURNAL OF CANCER

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis

(2014) Peiwei Li et al.   GUT

Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination

(2013) A. Bhattacharya et al.   CARCINOGENESIS

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

(2013) Paul E. Goss et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib

(2013) Robert Ramer et al.   JOURNAL OF LIPID RESEARCH

The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line

(2013) Vincenzo Pagliarulo et al.   Molecular Cancer

Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials

(2012) Edward J. Mills et al.   AMERICAN JOURNAL OF MEDICINE

Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53

(2012) VR Katkoori et al.   BIOTECHNIC & HISTOCHEMISTRY

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

(2012) Zhi-Jun Dai et al.   Cancer Cell International

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of estrogens in serum and plasma from postmenopausal women: Past present, and future

(2010) Ian A. Blair   STEROIDS

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials

(2008) Scott D. Solomon et al.   CIRCULATION

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib

(2008) Luc Yves Dirix et al.   JOURNAL OF CLINICAL ONCOLOGY

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer

(2008) J.-A. W. Chapman et al.   JNCI-Journal of the National Cancer Institute